Combined mediator antagonism for allergic rhinitis.

about

Montelukast in allergic rhinitis: a systematic review and meta-analysis.

P2860

Q36609797-748DCD28-DE27-4565-AD8F-2F8528A546D8

P2860

Combined mediator antagonism for allergic rhinitis.

Item

http://www.wikidata.org/entity/Q44775741

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Combined mediator antagonism for allergic rhinitis.

@en

Combined mediator antagonism for allergic rhinitis.

@nl

type

Item

label

Combined mediator antagonism for allergic rhinitis.

@en

Combined mediator antagonism for allergic rhinitis.

@nl

prefLabel

Combined mediator antagonism for allergic rhinitis.

@en

Combined mediator antagonism for allergic rhinitis.

@nl

P1476

Combined mediator antagonism for allergic rhinitis.

@en

P2093

Jackson CM

http://www.w3.org/2001/XMLSchema#string

Lipworth BJ

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging role of antileukotriene therapy in allergic rhinitis

Allergic inflammation in the unified airway: start with the nose

The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

Allergic rhinitis and its impact on asthma.

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.

P304

276-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1398-9995.2003.00431.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8684578

http://www.w3.org/2001/XMLSchema#string

P698

14982508

http://www.w3.org/2001/XMLSchema#string

Combined mediator antagonism for allergic rhinitis.

about

P2860

P2860

Combined mediator antagonism for allergic rhinitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698